Dr M Linnett considers the factors which influence prescribing habits and outlines the questions which should be asked before committing a patient to a new drug.
Dr Michael Linnett (London)
I was brought up under the system whereby pharmacology was taught during the pre-clinical years, together with anatomy, physiology and biochemistry. Our teacher was a colourful old doctor whose lectures were enlivened by spicy anecdote and pungent aphorism, and I well remember the glee with which he offered a prize for a Christmas competition, to be awarded for the best sonnet on carminatives. I am sure that all this promoted our spiritual welfare, but it was quite unrelated to our later experience in the wards, and indeed I found I had to relearn the subject as applied pharmacology when I reached hospital.
There is one thing that the young student of today does not learn, and I doubt if it is possible to teach him before he qualifies, so great are the demands on teaching time, and that is our present subjectsensible prescribing habits in general practice. When he assumes his first responsibilities as a houseman in hospital, he will be one unit in a chain which should, and usually does, check at many stages what drug the patient is receiving; how much, how frequently, and above all why. But as soon as he leaves hospital and enters the quite different world of general practice, the young doctor finds out that things are not what they seem, and certainly have little of the relative security of the hospital system. It is by no means certain that the drugs he prescribes will be taken exactly as he wishes, however carefully he explains his intentions. In fact it has been estimated that there is only a 50 % chance of their being taken at all. Even if they are taken, the dose and frequency may be modified by the patient having forgotten what he was told, having failed to decipher the chemist's label, having felt that twice the dose would do twice the good in half the time, or having found the first dose distasteful or so disastrous that the rest was thrown out at once.
So that if he is himself initiating a course of treatment, as distinct from attempting to continue a regime initiated in hospital, he begins to form one habit at oncethat of keeping treatment as simple as possible using the simplest drugs available, and trying to cultivate the art of explaining clearly to the patient why the drug is being given, what it is expected to do, and what side-reactions if anymay be encountered. This last point needs much care -patients who are put on sulphonamides still ask whether it is safe for them to take eggs, and there is a widespreadbelief that taking antibiotics precludes any other tablet, including aspirin. But clearly with some drugs side-reactions may be frequentdryness of the mouth and slight blurring of the vision with anticholinergic drugs in treating dyspepsia, Proc. roy. Soc. Med. Volume 61 June 1968 depression with reserpine, dietary and pharmacological problems with monoamine-oxidase inhibitors, and rarer serious reactions such as agranulocytosis from phenylbutazone, to name but a fewbut just as failure to mention sideeffects may arouse indignation in the patient who experiences them, so undue emphasis may put the patient off a drug which will start him on the road to recovery.
Adverse reactions to drugs are of course in the front of everyone's mind at present and I should like very much to see the regular issue of a publication listing concisely the adverse effects, and, where it can be ascertained, their frequency, of all new drugs and all the newer drugs in common use since the war. There are obvious problems in this project, such as the possibility of a very new drug being unjustly given a bad reputation by a reported adverse effect which is not later confirmed, but I cannot believe that they are insurmountable.
How do doctors learn of new drugs, and how often do they use them? Since the thalidomide disaster, many doctors have been even more cautious with them. The Sainsbury Committee's report contains some interesting information on this point (Minister of Health and Secretary of State for Scotland 1967). In a survey carried out in 1966 involving 463 doctors in various parts of the country, 34% considered drug firm representatives to be the best source of information about the existence of new drugs, and 31 % thought articles from journals the best source for finding out about their efficacy. Other sources for both types of information included recommendations from consultants, contacts with other doctors, articles in Prescribers' Journal, Drugs & Therapeutics Bulletin and other journals, drug firm literature, MIMS (Monthly Index of Medical Specialities), refresher courses, &c. But it was interesting that 20% of the sample had prescribed no new preparations in the preceding three months, while 35 % had used one or two, and 40% three or more. The singlehanded older practitioner predominated amongst those who had not added to their repertoire; and the more new drugs that were used, the younger the age-group of doctor. Drug firm representatives can be a useful source of information about new drugs, and indeed they should be, for the nation, through the industry, according to Sainsbury, spends £7 million, or some £250 a year per practising doctor, on sales promotion by their means. But we must remember that, however good they may be, they can never in themselves constitute sufficient authority for the use of new preparations.
What questions should we ask ourselves before committing our patients to a new drug? I would suggest three:
(1) Does the drug really seem to offer advantages over its predecessorsor is it just a molecular reshuffle about a familiar theme, with no proven advantage over other drugs in the field?
(2) Do the published reports convincingly demonstrate the advantages claimed, with properly controlled trials done on a large enough scale to exclude bias?
(3) How much is known about the toxicity of the drug, or of the group of drugs from which it came, and what are the limitations on its use?
Habits in prescribing are formed unconsciously, in response to training, practice circumstances, the type of illness most frequently met with, and many other formative influences. Many have said before, and I still believe, that a small repertoire of tried, well-chosen weapons in which one has confidence produces far better and more consistent results than the random use of a large number of different drugs in the hope that one will turn out to be superior to the others. And yet I doubt if any practising family doctor could guarantee to justify on grounds of strict pharmacological relevance every prescription that he writes. We all know, for example, the old patient taken over from a retired colleague, who has always had a bottle of Dr Jones' tonic when he's feeling down, and it always did the trick. There may be little or no pharmacological virtue in the components of the prescription, but it would be an unwise and unkind doctor who decried the prescription and substituted for it something in which the patient had no faith.
Analysis of EClOs written throughout the country reveals many interesting facts about prescribing habits in general, one of which is connected with what I have just saidthat is, that the old Mist. Pot. Brom. and Nux Vomica is still a very commonly used prescription. It is no longer to be found in the British National Formulary (though the gentian mixtures are there to provide comfort for those who need them), but clearly many doctors continue their habit of using it because they have more faith in it than more modem or more powerful remedies. From the same source one perceives the rapid increase in the prescription of tranquillizers and sedatives, and I often feel, as I try to help relieve the tensions and anxieties of some over-stressed, over-driven individual, that the habit we have so rapidly formed, of treating the results of an unhealthy Section ofGeneral Practice civilization by the temporary relief of tablets, may well be condemned in its turn by later generations, as we now tend to condemn the 'tonic'.
Prescribing habits need constant re-examination and re-appraisal. It is a salutary experience to learn by examining the bathroom cupboard how many of your prescriptions have been dispensed only to remain shut up in their moist entirety, while you congratulated the patient on his recoveryand yourself on your pharmacological acumen. It is valuable, too, to review one's habits in the light of modern knowledge of the effects of drugs in combination, that, for example, salicylates in combination with oral antidiabetic drugs cause potentiation of their hypoglycaemic effect, or with warfarin may potentiate its anticoagulant effect.
In fact, in prescribing, as in so many other spheres, blind habit is a snare, but carefully formed habits are valuable and time saving. We all need time to select, from the mass of material thrust on us from all sides, those drugs which really will help our patients in the quickest and safest way, and to do this we must use every means available of acquiring impartial information. But above all we must try to retain, as it were, a due sense of questioning independence of mind over our habits of prescribing, so that as family doctors our special knowledge of our patients may help us to select the treatment for them that is most appropriate for their particular circumstances. The first essential for a prescription is that it be so written that the intention of the prescriber can be clearly understood by the dispenser, both as to content and method of use. Providing this is done it is not, in my view, important whether the prescription is written in Latin, abbreviated Latin, English or indeed a mixture of all three.
Until recent times, the vast majority of prescriptions were compounded (secundum artem) in the pharmacy, the names of the drugs used coming mostly from the botanical names of the plants which produced them. The use of abbreviated Latin was, therefore, most convenient. Each medicament prescribed would normally contain a number of ingredients. If, therefore, one ingredient was indecipherable the others would lend clues to its identity. Today, a large percentage of the items prescribed have been formulated and compounded by the pharmaceutical industry. A brand name is attached and if it is indecipherable the dispenser will have no clue as to its identity, unless, perhaps, another medicament is prescribed simultaneously. It has thus become increasingly important for the prescription to be written in such a way that the prescriber's intention is never in doubt.
There are slightly different legal requirements to be complied with in dispensing private and NHS prescriptions. It is my intention to confine myself in the main to NHS prescriptions.
There are three classes of medicines that may not be supplied to the public except on prescription. These are controlled by the following Acts and Regulations:
(1) The Therapeutic Substances Act (TSA) and Regulations: Drugs covered by these include most antibiotics and corticosteroids, isoniazid and its derivatives. All prescriptions must be signed and dated by the prescriber.
(2) Schedule 4. Poisons: We are concerned with Part a and Part b of the fourth schedule; 4b, for example, includes oral contraceptives and 4a the barbiturates, &c. In both cases the prescription must be in writing and must be signed anci dated by the prescriber. If coming under 4a it must also include: (i) Address of prescriber (except in the case of an NHS prescription). (ii) Name and address of patient. (iii) Total amount to be supplied (except in the case of BNF preparations). (iv) The dose (except in the case of external preparations). Unless the prescription contains all these particulars the pharmacist is not permitted to supply the medicine.
(3) The Dangerous Drugs Act (DDA): The requirements for prescriptions calling for the supply of drugs controlled under this Act differ slightly from those of Schedule 4 and TSA, in that the pharmacist must be acquainted with the signature of the prescriber or have taken reasonably sufficient steps to assure himself that it is genuine.
